Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer

974.4000 -0.55 (-0.06%)

NSE Jun 16, 2025 15:31 PM

26.42% Fall from 52W High

Volume: 777.6K

Zydus Lifesciences Ltd.

28 Nov 2022

974.40

-0.06%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Zydus receives tentative approval from the USFDA for Levothyroxine Sodium for Injection

More from Zydus Lifesciences Ltd.

Recommended

Chart of the Week: FIIs raise bets in consumer-driven sectors over the year

The Baseline | 16 Jun 2025, 05:21PM

IPOs This Week: Oswal Pumps and Three Others to List; Arisinfra Plus Five New Issues

| 16 Jun 2025, 05:10PM

Earnings Call Transcript - Cadila Healthcare